Herbas VPB

Print
EN | LT
Supplementary protection
LT - Šeiminės Viduržemio jūros karštligės gydymas su anti-IL-1 beta antikūnais
EN - Treatment of familial Mediterranean Fever with anti IL-1beta antibodies
SPC
(11) Number of the document C 2848258
(68) Number of the document 2848258
(21) Application number for Supplementary Protection Certificate PA 2018 506
(22) Date of filing the application 2018-06-12
(41) Date of publication of the application 2018-06-25
Date of publication of SPC 2019-08-12
(24) Date of coming into effect of SPC 2026-10-25
Applicant
(71) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/09/564, 2017-02-23
Calculated date of expiry of the SPC
(94) 2031-10-24
Name of the product protected by the basic patent
(95) Kanakinumabas
Legal status
SPC lapsed
Date of negative decision to issue the SPC 2021-06-16
Last update date 2021-11-25